The dopamine transporter in eating disorders: Uncovering new therapeutic targets
饮食失调中的多巴胺转运蛋白:发现新的治疗靶点
基本信息
- 批准号:8771759
- 负责人:
- 金额:$ 21.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:17 year oldAcuteAddressAdolescenceAdolescentAdultAffectAffinityAgeAnorexiaAttenuatedBehavioralBinge EatingBiological ModelsBody Weight decreasedBrain regionBulimiaCharacteristicsCocaineComplexCorpus striatum structureDataDietDiseaseDopamineDorsalDoseEatingEating BehaviorEating DisordersElderlyElectrochemistryEtiologyExerciseExtracellular FluidFatty acid glycerol estersFeeding behaviorsFemaleFemale AdolescentsFoodFunctional disorderFutureGoalsHomeostasisHumanHungerHyperactive behaviorHypersensitivityIndividualInjection of therapeutic agentInsulinInvestigationKnowledgeMeasuresMental DepressionMitogen-Activated Protein KinasesModelingMotivationMotor ActivityNeuronsOutcomePatientsPharmaceutical PreparationsPhosphotransferasesPlasmaPopulationProtein KinasePublic HealthRampRattusReadingRegulationReportingRewardsRodentRoleSeveritiesSex BehaviorSex CharacteristicsSex FunctioningSignal TransductionTherapeutic InterventionTimeaddictionage relatedbaseboysdopamine transporterdrug of abuseeffective therapyfeedingfood addictiongirlsimprovedin vivoinsightinsulin sensitivitymaleneurochemistryneurotransmissionnew therapeutic targetnovelpreventpublic health relevanceresponsesexstatisticsuptake
项目摘要
DESCRIPTION (provided by applicant): Although eating disorders are complex and their etiology unclear, dysregulation of dopamine neurotransmission is a consistent finding. A vital regulator of dopamine neurotransmission is the dopamine transporter (DAT). DAT terminates dopamine neurotransmission by uptake of dopamine from extracellular fluid and because of this DAT is a primary determinant of both the strength and duration of dopamine signaling. In spite of its critical role in maintaining dopamine homeostasis, there have been no investigations of DAT function, per se, in eating disorders. Using neurochemical, cellular and behavioral approaches, we have shown that DAT activity is highly sensitive to diet and food intake, strongly supporting the notion that DAT activity is dysregulated in individuals with eating disorders. However, studies so far have been in adult, male rodents. Anorexia, bulimia and binge eating are most common in teenage girls. What is lacking in our fundamental understanding of DAT is how its activity varies as a function of age and sex and, importantly, how age and sex interact to contribute to "disordered eating". In turn, how does aberrant DAT activity contribute to "disordered eating"? Here we will begin to fill these critical knowledge gaps. We will make use of the "activity-based anorexia" (ABA) model in rats to determine how age, sex and "eating disorder" influence DAT function and how manipulations of DAT activity modify eating behavior. The ABA model recapitulates key characteristics of anorexia in humans, including reduced food intake in the presence of hunger, weight loss, hyperactivity, and increased insulin sensitivity. Importantly, in this model rats must "choose" between eating and another rewarding condition, exercise. Thus, food intake is controlled by the rat and not artificially by the experimenter, offering a powerful translational model system. We will explore phosphotidylinositol 3-kinase (PI3K) and extracellular signal-regulated protein kinase (ERK), regulators of DAT activity that we have identified as putative targets to restore normal DAT function, as novel targets for therapeutic intervention to prevent, or lessen the severity of ABA. Given the well-established role of dopamine in reward and motivation, these studies will not only provide mechanistic insight into dysregulation of dopamine neurotransmission in eating disorders, but also other illnesses, including addiction and depression, which are often co-morbid with eating disorders.
描述(申请人提供):虽然进食障碍是复杂的,其病因尚不清楚,但多巴胺神经传递的失调是一个一致的发现。多巴胺神经传递的一个重要调节因子是多巴胺转运体(DAT)。DAT通过从细胞外液中摄取多巴胺来终止多巴胺的神经传递,因此DAT是多巴胺信号强度和持续时间的主要决定因素。尽管DAT在维持多巴胺动态平衡方面起着关键作用,但还没有关于DAT本身在饮食失调中的作用的研究。使用神经化学、细胞和行为方法,我们已经证明DAT活动对饮食和食物摄入量高度敏感,有力地支持了DAT活动在饮食障碍患者中调节失调的观点。然而,到目前为止,研究都是在成年雄性啮齿动物身上进行的。厌食症、暴食症和暴饮暴食在少女中最为常见。我们对DAT的基本了解不足的是,它的活动如何随着年龄和性别的变化而变化,以及重要的是,年龄和性别是如何相互作用,导致“饮食失调”的。反过来,DAT活性异常是如何导致“饮食失调”的呢?在这里,我们将开始填补这些关键的知识空白。我们将利用大鼠的“基于活动的厌食症”(ABA)模型来确定年龄、性别和“进食障碍”如何影响DAT功能,以及DAT活动的操纵如何改变饮食行为。ABA模型概括了人类厌食症的主要特征,包括饥饿、体重减轻、多动和胰岛素敏感性增加时的食物摄入量减少。重要的是,在这个模型中,老鼠必须在饮食和另一种有益的条件--锻炼--之间做出“选择”。因此,食物摄入量是由大鼠控制的,而不是由实验者人工控制的,这提供了一个强大的翻译模型系统。我们将探索磷酸肌醇3-激酶(PI3K)和细胞外信号调节蛋白激酶(ERK)这两种DAT活性的调节因子,作为预防或减轻ABA严重程度的治疗干预的新靶点。鉴于多巴胺在奖赏和动机中的作用已经得到证实,这些研究不仅将为饮食障碍中多巴胺神经传递的失调提供机械性的洞察,还将为其他疾病提供机制上的洞察,包括成瘾和抑郁,这些疾病通常与饮食障碍并存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LYNETTE C DAWS其他文献
LYNETTE C DAWS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LYNETTE C DAWS', 18)}}的其他基金
Uptake2 transporters: Novel sex-dependent molecular targets to treat stimulant use disorder
Uptake2转运蛋白:治疗兴奋剂使用障碍的新型性别依赖性分子靶标
- 批准号:
10595444 - 财政年份:2023
- 资助金额:
$ 21.68万 - 项目类别:
Organic cation transporter 3: a novel molecular target to treat amphetamine abuse
有机阳离子转运蛋白 3:治疗苯丙胺滥用的新型分子靶点
- 批准号:
9808668 - 财政年份:2019
- 资助金额:
$ 21.68万 - 项目类别:
Exploring a role for organic transporter 3 in the mechanism of action of drugs of abuse
探索有机转运蛋白 3 在滥用药物作用机制中的作用
- 批准号:
9788402 - 财政年份:2018
- 资助金额:
$ 21.68万 - 项目类别:
Age-related differences in serotonin clearance: novel targets for antidepressants
血清素清除率与年龄相关的差异:抗抑郁药的新目标
- 批准号:
9062518 - 财政年份:2015
- 资助金额:
$ 21.68万 - 项目类别:
The dopamine transporter in eating disorders: Uncovering new therapeutic targets
饮食失调中的多巴胺转运蛋白:发现新的治疗靶点
- 批准号:
8845537 - 财政年份:2014
- 资助金额:
$ 21.68万 - 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
- 批准号:
8424968 - 财政年份:2012
- 资助金额:
$ 21.68万 - 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
- 批准号:
8262100 - 财政年份:2012
- 资助金额:
$ 21.68万 - 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
- 批准号:
8581356 - 财政年份:2012
- 资助金额:
$ 21.68万 - 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
- 批准号:
8969703 - 财政年份:2012
- 资助金额:
$ 21.68万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 21.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 21.68万 - 项目类别:
Standard Grant